These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3951348)

  • 1. [Radiation risk during radionuclide diagnosis of thyroid diseases].
    Iakovleva NG
    Med Radiol (Mosk); 1986 Feb; 31(2):46-8. PubMed ID: 3951348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial.
    Nielsen VE; Bonnema SJ; Boel-Jørgensen H; Veje A; Hegedüs L
    J Clin Endocrinol Metab; 2005 Jan; 90(1):79-83. PubMed ID: 15494456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition of nodular toxic goiter to autoimmune hyperthyroidism triggered by 131I therapy.
    Nygaard B; Faber J; Veje A; Hegedüs L; Hansen JM
    Thyroid; 1999 May; 9(5):477-81. PubMed ID: 10365679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of factors affecting treatment results for toxic goiter with radioactive 131I].
    Listewnik MH
    Ann Acad Med Stetin; 2000; 46():109-21. PubMed ID: 11712298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some comparative studies using 99mTc and 131I in thyroid scanning.
    Górowski T; Chomicki OA
    Nuklearmedizin; 1976 Dec; 15(6):268-72. PubMed ID: 1012920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.
    Fast S; Hegedüs L; Grupe P; Nielsen VE; Bluhme C; Bastholt L; Bonnema SJ
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3719-25. PubMed ID: 20519346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytogenetic study of thyroid patients treated with external irradiation or radioiodine].
    Katz N; Esik O; Füzy M; Gundy S
    Orv Hetil; 1998 Jun; 139(25):1521-6. PubMed ID: 9676113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosome aberrations after treatment with radioactive iodine for thyroid cancer.
    Baugnet-Mahieu L; Lemaire M; Léonard ED; Léonard A; Gerber GB
    Radiat Res; 1994 Dec; 140(3):429-31. PubMed ID: 7972697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
    Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
    J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetry and risk estimates of radioiodine therapy for large, multinodular goiters.
    Huysmans DA; Buijs WC; van de Ven MT; van den Broek WJ; Kloppenborg PW; Hermus AR; Corstens FH
    J Nucl Med; 1996 Dec; 37(12):2072-9. PubMed ID: 8970537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
    Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
    Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.
    Huysmans DA; Nieuwlaat WA; Erdtsieck RJ; Schellekens AP; Bus JW; Bravenboer B; Hermus AR
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3592-6. PubMed ID: 11061507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative evaluation of radionuclide and ultrasonic studies of the thyroid].
    Epshteĭn EV; Kashkadamov AV; Imshinetskiĭ PV; Zybina GA
    Med Radiol (Mosk); 1989 Jun; 34(6):9-13. PubMed ID: 2544779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Place of nuclear medicine methods in thyroid diagnosis].
    Studer H; König MP
    Schweiz Med Wochenschr; 1984 Mar; 114(11):361-4. PubMed ID: 6546807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum thyroglobulin is elevated in patients with heterogeneous goiter during radioiodide scintigraphy, but normal in those with homogeneous goiter].
    Izembart M; Heshmati HM; Dagousset F; de Cremoux P; Boutteville C; Vallée G
    Schweiz Med Wochenschr; 1986 May; 116(19):634-7. PubMed ID: 3715440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine treatment of hyperthyroidism in patients with low thyroid uptake.
    Ruchała M; Sowiński J; Dolata M; Junik R; Gembicki M; Skiba A
    Nucl Med Rev Cent East Eur; 2005; 8(1):28-32. PubMed ID: 15977144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected finding on [131I]iodine scintigraphy: Warthin tumor in a patient with toxic nodular goiter referred for radioiodine treatment.
    Aulich A; Cichocki P; Stefański B; Adamczewski Z
    Pol Arch Intern Med; 2024 Jan; 134(1):. PubMed ID: 38019146
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes of the blood lymphocyte population following 131I treatment for nodular goiter.
    Blomgren H; Petrini B; Wasserman J; Schnell PO; Lundell G
    Int J Radiat Oncol Biol Phys; 1987 Feb; 13(2):209-15. PubMed ID: 3818387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standard dose 131I therapy for toxic multinodular goiter in an endemic goiter region.
    Gonçalves E; Castro JA; Gross JL
    Braz J Med Biol Res; 1986; 19(6):723-9. PubMed ID: 3651625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma.
    M'Kacher R; Legal JD; Schlumberger M; Voisin P; Aubert B; Gaillard N; Parmentier C
    J Nucl Med; 1996 Nov; 37(11):1860-4. PubMed ID: 8917193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.